CIK 0001367644
- Accelerated filer
Emergent BioSolutions Inc.
Sign in to watch- Ticker
- EBS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 141902018
- Phone
- +1 240-631-3200
- Business address
- 300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
- 4 Returned to the company SVP, Products Business returned 8,655 shares (to the company)
- 4 Returned to the company SVP, Bioservices returned 5,771 shares (to the company)
- 4 Returned to the company EVP, Chief Financial Officer returned 46,155 shares (to the company)
- 4 Shares withheld for taxes SVP, R&D, CMO gave up 3,543 shares (to pay taxes)
- 4 Open-market sale Director sold 21,984 shares at an average $11.97 ($263,077)
- 4 Shares withheld for taxes SVP, Bioservices gave up 610 shares (to pay taxes)
- 4 Open-market sale Director sold 17,801 shares at $10.54 ($187,623)
- 4 Open-market sale Director sold 8,552 shares at $10.00 ($85,520)
- 4 Shares withheld for taxes EVP, Chief Financial Officer gave up 4,995 shares (to pay taxes)
- 4 Open-market sale EVP, Quality & Ethics, and CPL sold 30,608 shares at $10.00 ($306,080)
- 4 Planned sale Director sold 7,086 shares at $8.87 ($62,853)
- 4 Open-market sale Director sold 7,844 shares at $8.65 ($67,831)
- 4 Shares withheld for taxes SVP, Bioservices gave up 4,263 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Bioservices gave up 1,167 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Quality & Ethics, and CPL gave up 1,249 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Products Business gave up 464 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Chief Financial Officer gave up 2,733 shares (to pay taxes)
- 4 Planned sale Director sold 7,844 shares at $6.30 ($49,417)
- 4 Open-market buy President and CEO bought 60,000 shares at $5.83 ($349,800)
- 4 Grant or award Director acquired 34,403 shares (grant or award)
Page 3 of 49 · 970 filings